# StemGen, Inc.

StemGen, Inc. is a company headquartered in Houston, TX, United States.

## Company overview

- **Legal name:** StemGen, Inc.
- **Former names in filing history:** AMASYS CORP (1996-10-15 to 2013-02-04)
- **Classification:** Company
- **Industry (SIC):** 7372 — Services-Prepackaged Software
- **Headquarters:** Houston, TX, United States
- **Incorporated in:** DE
- **Fiscal year end:** June 30
- **SEC CIK:** 0001023198

## About

StemGen, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001023198, and its reported industry is Services-Prepackaged Software. In 10-K filed on 2015-10-13, it reported net income of USD -491,999 for the fiscal period ended 2015-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-06-30)

- **Net income:** -$491,999 (USD -491,999)
- **Operating cash flow:** -$107,419 (USD -107,419)

### FY2014 (period ended 2014-06-30)

- **Net income:** $16,420 (USD 16,420)
- **Total assets:** $80 (USD 80)
- **Cash and equivalents:** $80 (USD 80)
- **Operating cash flow:** -$122,760 (USD -122,760)

### FY2013 (period ended 2013-06-30)

- **Revenue:** $0 (USD 0)
- **Net income:** -$88,419 (USD -88,419)
- **Total assets:** $840 (USD 840)
- **Cash and equivalents:** $840 (USD 840)
- **Operating cash flow:** $5,495 (USD 5,495)

### FY2012 (period ended 2012-06-30)

- **Revenue:** $0 (USD 0)
- **Net income:** -$68,370 (USD -68,370)
- **Total assets:** $564 (USD 564)
- **Cash and equivalents:** $564 (USD 564)
- **Operating cash flow:** -$18,861 (USD -18,861)

## Recent SEC filings

- Form 10-Q — filed 2022-08-04 — period 2022-03-31 — FORM 10-Q QUARTERLY REPORT FOR 03-31-2022
- Form 10-Q — filed 2022-02-23 — period 2021-12-31 — FORM 10-Q QUARTERLY REPORT FOR 12-31-2021
- Form 10-Q — filed 2022-02-07 — period 2021-09-30 — FORM 10-Q QUARTERLY REPORT FOR 09-30-2021
- Form 10-K — filed 2021-10-15 — period 2021-06-30 — FORM 10-K ANNUAL REPORT FOR 06-30-2021
- Form 10-Q — filed 2021-05-24 — period 2021-03-31 — FORM 10-Q QUARTERLY REPORT FOR 03-31-2021
- Form 10-Q — filed 2021-02-22 — period 2020-12-31 — FORM 10-Q QUARTERLY REPORT FOR 12-31-2020
- Form 8-K — filed 2021-02-08 — period 2021-01-01 — FORM 8-K CURRENT REPORT FOR 01-01-2021
- Form 10-Q — filed 2020-11-16 — period 2020-09-30 — FORM 10-Q QUARTERLY REPORT FOR 09-30-2020
- Form 10-K — filed 2020-10-09 — period 2020-06-30 — FORM 10-K ANNUAL REPORT FOR 06-30-2020
- Form 10-Q — filed 2020-06-10 — period 2020-03-31 — FORM 10-Q QUARTERLY REPORT FOR 03-31-2020
- Form 8-K — filed 2020-03-20 — period 2020-03-19 — FORM 8-K CURRENT REPORT FOR 03-19-2020
- Form 8-K — filed 2020-03-03 — period 2020-03-02 — FORM 8-K CURRENT REPORT FOR 03-02-2020

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/stemgen-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology